Wilson's Disease Clinical Trial
Official title:
Phase3, Open-Label, Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.
The purpose of this long-term study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.
Wilson disease is an autosomal recessive disorder with copper metabolism. In Japan, the standard treatment is the use of copper chelating agents, such as D-penicillamine and trientine. In this study, we investigate efficacy on zinc acetate in Japanese patients with Wilson disease. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04537377 -
A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06051734 -
Early Detection of Cardiac Affection in Patients of Wilson's Disease
|
||
| Active, not recruiting |
NCT02252380 -
ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders
|
N/A | |
| Completed |
NCT01874028 -
A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients
|
Phase 1 | |
| Recruiting |
NCT05183165 -
Description of the Copper Concentration in Breast Milk in Women Treated for Wilson's Disease
|
N/A | |
| Recruiting |
NCT05493605 -
Cardiac Involvement in Wilson's Disease
|
N/A | |
| Recruiting |
NCT03957720 -
The Individual Therapy for Patients With Wilson's Disease
|
Early Phase 1 | |
| Recruiting |
NCT05239858 -
International Wilson's Disease Patient Registry (iWilson Registry)
|
||
| Recruiting |
NCT04012658 -
A Registered Cohort Study on Wilson's Disease
|
||
| Completed |
NCT02552628 -
WILSTIM - DBS (WILson STIMulation - Deep Brain Stimulation)
|
N/A | |
| Completed |
NCT06128954 -
Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily).
|
Phase 1 | |
| Recruiting |
NCT05305872 -
Gandouling in the Treatment of Wilson's Disease
|
Phase 4 | |
| Recruiting |
NCT04212195 -
Cohort Research on Wilson's Disease
|
||
| Completed |
NCT01378182 -
Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis
|
N/A |